Advanced end-to-end solutions underpinning the development of vaccines to combat infectious diseases.
Unrivalled Expertise in Vaccine Development
Synexa Life Sciences offers a comprehensive array of solutions designed to assess the efficacy and immunogenicity of vaccine candidates. Our vaccine services are meticulously designed to investigate both cellular and humoral immune responses, providing a holistic view of vaccine efficacy.
Utilising advanced techniques such as flow cytometry, MHC multimer analysis and cutting-edge immunoassays, we enable customers to delve deeply into the immune responses elicited by vaccines. Through rigorous evaluations, we empower customers with the critical data needed to make informed decisions, facilitating the development of vaccines that are both safe and effective.
Our Vaccine Services
Humoral Response Analysis
Laboratory Solutions for Vaccine Clinical Trials
Learn more about our vaccine services and expertise.
Considering a vaccine study in Africa?
Learn more about our complete end-to-end vaccine service solution.
A complete end-to-end lab solution for vaccine development
Synexa has partnered with Cytespace Laboratories Africa to provide a complete end-to-end solution for vaccine development. Our combined expertise offers a comprehensive service, from central lab and safety marker analysis to intricate biomarker and bioanalysis, ensuring samples are prepared and processed to their fullest potential. With Cytespace as the central lab and Synexa handling specialist biomarker and bioanalytical analysis, this synergy provides industry leading vaccine study capabilities and streamlined laboratory testing.
The Scientific Partner of Choice for Biomarker and Bioanalytical Solutions
Bridging the gap between science and life.